Treatment Innovations
Innovations in cancer treatment are transforming patient care by introducing more precise, effective, and less invasive therapies. Immunotherapy, including checkpoint inhibitors and CAR-T cell therapy, has revolutionized cancer care by harnessing the immune system to target and destroy cancer cells.
Minimally invasive prostate cancer treatment shows success in first patient
Bill Faulkner had long approached prostate cancer testing with skepticism. For almost a decade, the 73-year-old had avoided the prostate-specific antigen test because of concerns about over-diagnosis; over-treatment; and, most of all, the potentially life-altering side effects of invasive surgical treatments.
Diabetes drug could help cancer patients make better recovery
A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.
New treatment offers hope for deadly brain cancer
A groundbreaking experimental treatment for glioblastoma, one of the deadliest brain cancers, has been published in Nature Medicine, bringing new hope for patients.
Silexion Therapeutics’ Preclinical Cancer Candidate Shows Tumor Reduction For Pancreatic Cancer
Silexion Therapeutics Corp. SLXN+1.65%+ Free Alertsreleased data on Wednesday from orthotopic pancreatic cancer models demonstrating that subcutaneously administered SIL204 effectively reduces primary tumor growth and metastatic spread.
Nanoparticle immune therapy shows potential to halt pancreatic cancer spread
Pancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced stages when the disease has already spread, or metastasized. About half of pancreatic cancer patients experience metastasis to the liver, which worsens the prognosis for an already life-threatening disease.
The timing breakthrough in liver cancer treatment
In a significant step forward for liver cancer treatment, researchers have found that a gap of at least 50 days between stopping immunotherapy and undergoing a liver transplant dramatically lowers the risk of graft rejection. This discovery offers new hope to patients battling hepatocellular carcinoma (HCC), the most common form of liver cancer globally.
New drug shows promise in treating childhood bone cancer
A new drug that works against the main types of primary bone cancer has been developed by researchers at the University of East Anglia and University of Sheffield.
How aspirin could be used to reduce your cancer risk
Aspirin has the potential to prevent certain forms of cancer from spreading, scientists have found, and could even be used as a cancer treatment in the future.
How genetic testing is leading to better treatments for childhood cancer
New research is bringing hope to children and young people with cancer by using genetic testing to match them with more effective and less harmful treatments.
Double trouble for tumors: Immunotherapy shows promise in prostate cancer treatment
Researchers at the University of Arizona Health Sciences have uncovered a promising new approach for treating prostate cancer through a combination of immunotherapy and a targeted treatment strategy.
New test may predict kidney cancer recurrence
Scientists at the University of Michigan have discovered a way to predict which kidney cancer patients are more likely to have their cancer come back after treatment. Their research could help doctors decide who needs extra treatment and who doesn’t, making care more personalized instead of using a “one-size-fits-all” approach.
Genetic testing offers hope for targeted childhood cancer therapies
New research has looked into a comprehensive and structured approach to genetic testing, matching children and young people with cancer to targeted treatments.
Could Salmonella Be the Key to Treating Bowel Cancer?
The concept of using bacteria to treat cancer dates back to the early 1800s, long before the advent of modern cancer treatments like chemotherapy or radiotherapy. Historical evidence suggests that rudimentary and crude forms of immunotherapy were practiced as early as Ancient Egypt. However, these early treatments of cancer using immunotherapy were risky and unreliable due to the lack of antibiotics and the potential for severe side effects.
Certain genetic alterations may contribute to primary resistance of certain cancers to KRAS G12C inhibitors
The KRAS G12C mutation is found in approximately 3% of all colorectal cancer cases and 1% to 2% of pancreatic adenocarcinoma cases, according to Hao Xie, MD, PhD, a medical oncologist at Mayo Clinic Comprehensive Cancer Center.
Aromatic Plant Found to Have Cancer-Fighting Properties Against Colorectal Cancer
Traditional Chinese medicine has used Artemisia annua, or sweet wormwood, for over 2,000 years to treat various ailments, including malaria and fever.
Study finds new potential for prostate cancer immunotherapy
A new study by University of Arizona Health Sciences researchers found that an immunotherapy previously shown to be ineffective against prostate cancer may have therapeutic potential when combined with a synergistic treatment approach. The paper was published in the journal Cancer Immunology Research.
Common malaria drug repurposed to fight cancer
Can a drug that’s used to treat malaria be repurposed to fight cancer? Researchers at The University of Texas at El Paso have secured a patent for the anti-malarial drug pyronaridine to do just that. Pyronaridine has been used to treat the mosquito-borne infectious disease for over 30 years.
Melatonin’s Anti-Cancer Potential; Prenatal PFAS and Cancer; Anti-Viral Gel for HPV
News, features, and commentary about cancer-related issues
Root cause of pancreatic cancer and new treatment
Pancreatic cancer is one of the deadliest forms of cancer. A specific type called pancreatic ductal adenocarcinoma, or PDAC, is especially aggressive. Right now, there are no truly effective treatments for this kind of cancer. Sadly, only about 8 out of every 100 people diagnosed with PDAC live longer than five years.
Scientists finds new treatment for lung cancer
Small-cell lung cancer (SCLC) is one of the most aggressive and deadly types of cancer, often linked to smoking.
The unseen team of medical detectives at Northwestern Medicine using advanced techniques for cancer detection, treatment
CHICAGO (WGN) — While machines can scan and surgeons cut, it takes a special kind of doctor to determine the presence of cancer in a patient.
A powerful drug combo may treat pancreatic cancer
Pancreatic cancer is one of the deadliest cancers in the world. Only about 13 out of every 100 people with this disease survive for five years after being diagnosed.
Breast cancer drug Supinoxin shows potential for small-cell lung cancer in new tests
Purdue University scientists have identified the Supinoxin small-molecule drug as a possible new therapy for small-cell lung cancer (SCLC).
Cell-free RNA blood test identifies early-stage cancers, monitors treatment resistance and detects tissue damage
Stanford Medicine researchers have developed a blood test capable of detecting cancers, the ways cancer resists treatments and tissue injury caused by non-cancerous conditions.
